Presentations

Modeling the Emergence of Resistance to Chemotherapeutics with Virtual Tumour

Dr Eric Fernandez, Project Leader

Translational modelling of vemurafenib, selumetinib and docetaxel in metastatic melanoma with Virtual Tumour Clinical

Dr Christophe Chassagnole, COO

Physiomics Showcase Presentation

Dr Marck Chadwick, CEO

Cancer Modeling and Drug Schedule Optimization

Dr Christophe Chassagnole, COO

Making better Cancer Therapies with Modelling

Dr. Christophe Chassagnole, COO

Systems Biology for Cancer Drug Development

Dr. Christophe Chassagnole, COO

Optimal cancer chronotherapeutics schedules using a Systems Biology approach – Chronotherapeutics of Seliciclib

Dr. Christophe Chassagnole, COO

Drug Discovery and the New Biology

Pr David A Fell, CSO